{"id":117473,"name":"INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM","slug":"international-pharmaceutical-aerosol-consortium","state":null,"country":"* Undetermined","description":"","totalSpending":0,"filings":32,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":["ENV"],"firms":["FAEGRE DRINKER BIDDLE & REATH LLP"],"lobbyists":["MAUREEN HARDWICK"],"govEntities":["SENATE","Environmental Protection Agency (EPA)"],"sampleDescriptions":["S. 2657, Advanced Geothermal Innovation Leadership Act of 2019.","Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic.","Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic; reclamation","Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic; reclamation","Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic; reclamation"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}